Brief: Harvard Bioscience Inc - Q4 2024 Revenues $24.6 Million
12/03/2025 11:04
March 12 (Reuters) - Harvard Bioscience Inc HBIO.O: HARVARD BIOSCIENCE INC - Q4 2024 REVENUES $24.6 MILLION HARVARD BIOSCIENCE INC - Q1 2025 REVENUE GUIDANCE $19 MILLION TO $21 MILLION Source text: [ID:n0001171843-25-001422] Further company coverage: HBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harvard Bioscience
See all newsBrief: Harvard Bioscience Announces Creation Of Scientific Advisory Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance